Previous close | 3.2800 |
Open | 3.3600 |
Bid | 3.1000 x 100 |
Ask | 3.2800 x 100 |
Day's range | 3.1800 - 3.3600 |
52-week range | 2.1000 - 4.3800 |
Volume | |
Avg. volume | 67,932 |
Market cap | 167.599M |
Beta (5Y monthly) | 1.20 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Discover how Alimera Sciences achieved remarkable revenue growth and strategic advancements in Q1 2024.
Alimera Sciences (ALIM) delivered earnings and revenue surprises of -200% and 2.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Call Transcript March 7, 2024 Alimera Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences Fourth […]